Literature DB >> 22328350

Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.

Valeria Latorre1, Sharon J Diskin, Maura A Diamond, Haitao Zhang, Hakon Hakonarson, John M Maris, Marcella Devoto.   

Abstract

BACKGROUND: Neuroblastoma is an often fatal pediatric cancer more frequent in European-American than African-American children. African-American children, however, are at higher risk for the more severe form of neuroblastoma and have worse overall survival than European-American children. Genome-wide association studies (GWAS) have identified several single-nucleotide polymorphisms (SNP) associated to neuroblastoma in children of European descent. Knowledge of their association to neuroblastoma in African-American children is still lacking.
METHODS: We genotyped and imputed SNPs located in three gene regions reported to be associated to neuroblastoma in children of European descent, and tested them for association in 390 African-American patients with neuroblastoma compared with 2,500 healthy, ethnically matched controls.
RESULTS: SNPs in the BARD1 gene region show a similar pattern of association to neuroblastoma in African-American and European-American children. The more restricted extent of linkage disequilibrium in the African-American population suggests a smaller candidate region for the putative causal variants than previously reported. Limited association was observed at the other two gene regions tested, including LMO1 in 11p15 and FLJ22536 in 6p22.
CONCLUSIONS: Common BARD1 SNPs affect risk of neuroblastoma in African-Americans. The role of other SNPs associated to neuroblastoma in children of European descent could not be confirmed, possibly due to different patterns of linkage disequilibrium or limited statistical power to detect association to variants with small effect on disease risk. Extension of GWAS to populations of African descent is important to confirm their results and validity beyond the European populations and can help to refine the location of the putative causal variants. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328350      PMCID: PMC3319325          DOI: 10.1158/1055-9965.EPI-11-0830

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

1.  A new multipoint method for genome-wide association studies by imputation of genotypes.

Authors:  Jonathan Marchini; Bryan Howie; Simon Myers; Gil McVean; Peter Donnelly
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

2.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

3.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.

Authors:  Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

4.  Copy number variation at 1q21.1 associated with neuroblastoma.

Authors:  Sharon J Diskin; Cuiping Hou; Joseph T Glessner; Edward F Attiyeh; Marci Laudenslager; Kristopher Bosse; Kristina Cole; Yaël P Mossé; Andrew Wood; Jill E Lynch; Katlyn Pecor; Maura Diamond; Cynthia Winter; Kai Wang; Cecilia Kim; Elizabeth A Geiger; Patrick W McGrady; Alexandra I F Blakemore; Wendy B London; Tamim H Shaikh; Jonathan Bradfield; Struan F A Grant; Hongzhe Li; Marcella Devoto; Eric R Rappaport; Hakon Hakonarson; John M Maris
Journal:  Nature       Date:  2009-06-18       Impact factor: 49.962

5.  Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study.

Authors:  Carolyn M Hutter; Alicia M Young; Heather M Ochs-Balcom; Cara L Carty; Tao Wang; Christina T L Chen; Thomas E Rohan; Charles Kooperberg; Ulrike Peters
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-27       Impact factor: 4.254

6.  International variations in the incidence of neuroblastoma.

Authors:  C A Stiller; D M Parkin
Journal:  Int J Cancer       Date:  1992-10-21       Impact factor: 7.396

7.  Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.

Authors:  John M Maris; Yael P Mosse; Jonathan P Bradfield; Cuiping Hou; Stefano Monni; Richard H Scott; Shahab Asgharzadeh; Edward F Attiyeh; Sharon J Diskin; Marci Laudenslager; Cynthia Winter; Kristina A Cole; Joseph T Glessner; Cecilia Kim; Edward C Frackelton; Tracy Casalunovo; Andrew W Eckert; Mario Capasso; Eric F Rappaport; Carmel McConville; Wendy B London; Robert C Seeger; Nazneen Rahman; Marcella Devoto; Struan F A Grant; Hongzhe Li; Hakon Hakonarson
Journal:  N Engl J Med       Date:  2008-05-07       Impact factor: 91.245

8.  Identification of ALK as a major familial neuroblastoma predisposition gene.

Authors:  Yaël P Mossé; Marci Laudenslager; Luca Longo; Kristina A Cole; Andrew Wood; Edward F Attiyeh; Michael J Laquaglia; Rachel Sennett; Jill E Lynch; Patrizia Perri; Geneviève Laureys; Frank Speleman; Cecilia Kim; Cuiping Hou; Hakon Hakonarson; Ali Torkamani; Nicholas J Schork; Garrett M Brodeur; Gian P Tonini; Eric Rappaport; Marcella Devoto; John M Maris
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

9.  Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.

Authors:  Mario Capasso; Marcella Devoto; Cuiping Hou; Shahab Asgharzadeh; Joseph T Glessner; Edward F Attiyeh; Yael P Mosse; Cecilia Kim; Sharon J Diskin; Kristina A Cole; Kristopher Bosse; Maura Diamond; Marci Laudenslager; Cynthia Winter; Jonathan P Bradfield; Richard H Scott; Jayanti Jagannathan; Maria Garris; Carmel McConville; Wendy B London; Robert C Seeger; Struan F A Grant; Hongzhe Li; Nazneen Rahman; Eric Rappaport; Hakon Hakonarson; John M Maris
Journal:  Nat Genet       Date:  2009-05-03       Impact factor: 38.330

10.  A flexible and accurate genotype imputation method for the next generation of genome-wide association studies.

Authors:  Bryan N Howie; Peter Donnelly; Jonathan Marchini
Journal:  PLoS Genet       Date:  2009-06-19       Impact factor: 5.917

View more
  40 in total

Review 1.  Genetic and nongenetic risk factors for childhood cancer.

Authors:  Logan G Spector; Nathan Pankratz; Erin L Marcotte
Journal:  Pediatr Clin North Am       Date:  2014-10-18       Impact factor: 3.278

2.  Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.

Authors:  Mario Capasso; Sharon J Diskin; Francesca Totaro; Luca Longo; Marilena De Mariano; Roberta Russo; Flora Cimmino; Hakon Hakonarson; Gian Paolo Tonini; Marcella Devoto; John M Maris; Achille Iolascon
Journal:  Carcinogenesis       Date:  2012-12-07       Impact factor: 4.944

3.  Next Generation Statistical Genetics: Modeling, Penalization, and Optimization in High-Dimensional Data.

Authors:  Kenneth Lange; Jeanette C Papp; Janet S Sinsheimer; Eric M Sobel
Journal:  Annu Rev Stat Appl       Date:  2014-01-01       Impact factor: 5.810

4.  Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.

Authors:  Laura E Egolf; Zalman Vaksman; Gonzalo Lopez; Jo Lynne Rokita; Apexa Modi; Patricia V Basta; Hakon Hakonarson; Andrew F Olshan; Sharon J Diskin
Journal:  Am J Hum Genet       Date:  2019-08-29       Impact factor: 11.025

5.  CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.

Authors:  Mike R Russell; Annalise Penikis; Derek A Oldridge; Juan R Alvarez-Dominguez; Lee McDaniel; Maura Diamond; Olivia Padovan; Pichai Raman; Yimei Li; Jun S Wei; Shile Zhang; Janahan Gnanchandran; Robert Seeger; Shahab Asgharzadeh; Javed Khan; Sharon J Diskin; John M Maris; Kristina A Cole
Journal:  Cancer Res       Date:  2015-06-22       Impact factor: 12.701

6.  Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.

Authors:  Eric R Gamazon; Navin Pinto; Anuar Konkashbaev; Hae Kyung Im; Sharon J Diskin; Wendy B London; John M Maris; M Eileen Dolan; Nancy J Cox; Susan L Cohn
Journal:  J Natl Cancer Inst       Date:  2012-12-14       Impact factor: 13.506

7.  Genome-wide pathway analysis in neuroblastoma.

Authors:  Young Ho Lee; Jae-Hoon Kim; Gwan Gyu Song
Journal:  Tumour Biol       Date:  2013-11-30

Review 8.  Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Authors:  Nai-Kong V Cheung; Michael A Dyer
Journal:  Nat Rev Cancer       Date:  2013-06       Impact factor: 60.716

9.  Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population.

Authors:  Jing He; Ruizhong Zhang; Yan Zou; Jinhong Zhu; Tianyou Yang; Fenghua Wang; Huimin Xia
Journal:  Tumour Biol       Date:  2015-08-26

10.  Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

Authors:  Derek A Oldridge; Andrew C Wood; Nina Weichert-Leahey; Ian Crimmins; Robyn Sussman; Cynthia Winter; Lee D McDaniel; Maura Diamond; Lori S Hart; Shizhen Zhu; Adam D Durbin; Brian J Abraham; Lars Anders; Lifeng Tian; Shile Zhang; Jun S Wei; Javed Khan; Kelli Bramlett; Nazneen Rahman; Mario Capasso; Achille Iolascon; Daniela S Gerhard; Jaime M Guidry Auvil; Richard A Young; Hakon Hakonarson; Sharon J Diskin; A Thomas Look; John M Maris
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.